Logo
I

Interius BioTherapeutics

57 employees

Interius is a clinical stage biotechnology company, engineering targeted, programmable vectors for the precision delivery of genetic medicines to treat an array of challenging diseases.

Investor insights

Funding rounds participated in

$51M sweet spot round size

Investor type

Privately Held

Basic info

Industry

Biotechnology Research

Sectors

Biotechnology Research

Funding rounds raised

Total raised

$51M

from investors over 1 rounds

I

Interius BioTherapeutics raised $51M on July 3, 2024

FAQ